Partnering fuels Sebela’s growth. We seek to leverage our development and commercial capabilities through acquisitions, in-licensing and partnering. We are focused on acquiring development programs that possess a validated target, high unmet medical need, and a known regulatory pathway with the FDA. Mid- to late-stage development programs as well as patent-protected marketed assets within our core therapeutic areas of Gastrointestinal Diseases and Women's Health are of particular interest to the business development team.

We closely collaborate with colleagues and advisors with deep medical, market, scientific, financial, transaction and alliance expertise to evaluate and structure valuable partnerships.

If you are interested in exploring business development opportunities with Sebela, please contact or use the form in the link below.